Abstract This paper is a research proposal to assess the effects on Chronic Fatigue Syndrome patients of increases in the serum levels of C-1 esterace inhibitor within the context of the concept of complement dis-regulation. This paper states that Chronic Fatigue Syndrome (CFS) is a clinically defined condition that is characterized by severe and disabling fatigue, but there is no validated diagnosis or treatment that will lead to a cure for CFS. The author will use Beck Depression Inventory (BDI) Kohlman Evaluation of Living Skills (KELS) and The Fatigue Inventory as the psychological measurements.
From the Paper "Clinical anxiety is defined within the context of feelings experienced by a person. At one level, anxiety is defined as a feeling of mingled dread and apprehension about a person's future where no specific cause for such dread and apprehension is present. At another level, anxiety is defined as a chronic feeling of fear by a person. This feeling may be mild in intensity or the feeling fear may be overwhelming for the person so affected. Anxiety also may be a secondary drive involving an acquired avoidance response. In this latter context, when in the presence of the conditioning stimulus, a person will display behavior that may be interpreted as evidence of the presence of anxiety. "
